Merit E. Cudkowicz, Md
Clinical trials sponsored by Merit E. Cudkowicz, Md, explained in plain language.
-
Massive ALS trial tests multiple drugs at once to find a way to slow the deadly disease
Disease control OngoingThis study is testing several experimental treatments at the same time to see if they can slow down ALS, a disease that weakens muscles and gets worse over time. About 1,500 adults with early-stage ALS will take part. The goal is to find treatments that help people stay stronger …
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New ALS drug trial hopes to slow disease progression
Disease control OngoingThis clinical trial is testing an oral drug called NUZ-001 in 160 people with ALS. Participants take the drug or a placebo daily for 36 weeks. The study measures how the disease progresses using a scale of physical function and survival. The goal is to see if NUZ-001 can slow ALS…
Phase: PHASE2, PHASE3 • Sponsor: Merit E. Cudkowicz, MD • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC